306 related articles for article (PubMed ID: 22617477)
21. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?
Pathiraja P; Sandhu H; Instone M; Haldar K; Kehoe S
Arch Gynecol Obstet; 2014 Mar; 289(3):657-62. PubMed ID: 24026090
[TBL] [Abstract][Full Text] [Related]
22. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
24. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
25. [Laparoscopy-assisted vaginal pelvic exenteration].
Ferron G; Querleu D; Martel P; Chopin N; Soulié M
Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
[TBL] [Abstract][Full Text] [Related]
26. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
27. [Combined surgical and radiotherapeutic treatment of pelvic wall recurrences: report of experiences after 3 years].
Höckel M; Knapstein PG; Hohenfellner R; Rösler HP; Kutzner J
Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):169-76. PubMed ID: 8467983
[TBL] [Abstract][Full Text] [Related]
28. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
Kanao H; Aoki Y; Hisa T; Takeshima N
Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary experience with the Miami type ileocolonic urinary reservoir in the practice of oncologic gynecology].
Sánchez-Valdivieso E; González Enciso A; Herrera Gómez A; Chávez Montes de Oca V; Muñóz González D
Arch Esp Urol; 2001 May; 54(4):327-33. PubMed ID: 11455766
[TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
31. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
32. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
[TBL] [Abstract][Full Text] [Related]
33. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
[TBL] [Abstract][Full Text] [Related]
34. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
35. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
Oranratanaphan S; Termrungruanglert W; Sirisabya N
Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
[TBL] [Abstract][Full Text] [Related]
37. Pelvic exenteration for the treatment of gynecological malignancies.
Numa F; Ogata H; Suminami Y; Tsunaga N; Nakamura Y; Tamura H; Takasugi N; Kato H; Tangoku A; Uchiyama T; Oka M; Suzuki T; Yamamoto M; Naito K
Arch Gynecol Obstet; 1997; 259(3):133-8. PubMed ID: 9187465
[TBL] [Abstract][Full Text] [Related]
38. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
[TBL] [Abstract][Full Text] [Related]
39. [Pelvic exenterations for gynaecological cancer--a 10 year institutional review].
Pinelo S; Petiz A; Domingues C; Lopes C; Alves A; Fael R
Acta Med Port; 2006; 19(2):99-104. PubMed ID: 17187709
[TBL] [Abstract][Full Text] [Related]
40. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
